Prosetta Biosciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
670 5th St, San Francisco, California, 9...Phone Number
(415) 346-8866Website
www.prosetta.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Prosetta Biosciences
Prosetta Biosciences is a biotechnology company based in San Francisco that specializes in developing innovative therapeutics for various diseases. The company focuses on identifying and advancing novel small molecules that modulate the assembly of multi-protein complexes within cells. Their technology aims to transform medicine by working in harmony with the body's regulatory mechanisms, offering a new strategy for restoring molecular homeostasis. Prosetta's intended clients include researchers and healthcare professionals in the field of drug discovery and disease treatment.Explore more
Prosetta Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prosetta Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Prosetta Biosciences is spiking on competitors!
Click to see if Prosetta Biosciences had a recent Job posting/layoffs
Check if Prosetta Biosciences has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Prosetta Biosciences launches new products
Funding: Get notified immidiatlly once Prosetta Biosciences has new funding data
Prosetta Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Prosetta Biosciences
Earning: See what the market has to say on Prosetta Biosciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Prosetta Biosciences
Compare insights from companies similar to Prosetta Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Prosetta Biosciences
<$5M
11-50
Private
$46.3M
2002
VL
Vishwanath LingappaCEO & Chief Technology Officer
Company Profile Activity
Activity Insights
Prosetta Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Prosetta Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Prosetta Biosciences.
Prosetta Biosciences financials insights
Gather financial insights about Prosetta Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$8M
2008
Series B
$5M
2012
Series C
$2M
2015
Series D
$31.1M
2021
Debt
$150K
Prosetta Biosciences Tech Stack
A closer look at the technologies used by Prosetta Biosciences
Prosetta Biosciences News & Media
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Prosetta Biosciences
Sign Up For FreeTo access detailed company insights
Prosetta Biosciences is a biotechnology company based in San Francisco that specializes in developing innovative therapeutics for various diseases. The company focuses on identifying and advancing novel small molecules that modulate the assembly of multi-protein complexes within cells. Their technology aims to transform medicine by working in harmo... Read More
